Amyloidosis Global Clinical Trials Research 2024
May 30, 2024 07:17 ET
|
Research and Markets
Dublin, May 30, 2024 (GLOBE NEWSWIRE) -- The "Amyloidosis - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The analyst's clinical trial...
ADC Therapeutics to Participate in the Jefferies Global Healthcare Conference
May 30, 2024 07:15 ET
|
ADC Therapeutics SA
LAUSANNE, Switzerland, May 30, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that Ameet Mallik, Chief Executive Officer, will present a company overview at the Jefferies...
North America Lithium Compound Market 2023-2032: Rising Demand for Lithium-Ion Batteries Encourages Market Expansion, Electronic Revolution and Ecological Initiatives Propel Growth
May 30, 2024 07:12 ET
|
Research and Markets
Dublin, May 30, 2024 (GLOBE NEWSWIRE) -- The "North America Lithium Compound Market Report by Type, End-Use, and Country 2024-2032" report has been added to ResearchAndMarkets.com's offering.The...
Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review 2024
May 30, 2024 07:10 ET
|
Research and Markets
Dublin, May 30, 2024 (GLOBE NEWSWIRE) -- The "Chronic Lymphocytic Leukemia (CLL) - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The...
Fixing of coupon rates - Nykredit Realkredit A/S
May 30, 2024 07:10 ET
|
Nykredit Realkredit A/S
To Nasdaq Copenhagen 30 May 2024 FIXING OF COUPON RATES Fixing of coupon rates effective from 3 June 2024 Effective from 3 June 2024, the coupon rates of floating-rate bonds issued...
Asia-Pacific's Beauty and Personal Care Transformative Market Megatrends to 2032
May 30, 2024 07:08 ET
|
Research and Markets
Dublin, May 30, 2024 (GLOBE NEWSWIRE) -- The "Unveiling Transformative Megatrends in Asia-Pacific's Beauty and Personal Care Market to 2032" report has been added to ResearchAndMarkets.com's...
Vigil Neuroscience to Present in Upcoming June Investor Conferences
May 30, 2024 07:05 ET
|
Vigil Neuroscience, Inc.
WATERTOWN, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of...
Global Polyamide in Electronics Protection Devices Market Projected to Reach $510.9 Million by 2032: Product and Application Advancements Driving Growth, Regional Market Insights and Future Outlook
May 30, 2024 07:04 ET
|
Research and Markets
Dublin, May 30, 2024 (GLOBE NEWSWIRE) -- The "Global Polyamide in Electronics Protection Devices Market by Product, Application, and Region 2024-2032" report has been added to ...
Incident IQ Partners with Level Access to Enhance Digital Accessibility
May 30, 2024 07:02 ET
|
Incident IQ
Atlanta, GA, May 30, 2024 (GLOBE NEWSWIRE) -- Incident IQ, a leader in workflow management solutions for K-12 school districts, has partnered with Level Access, the leading digital accessibility...
Elevar Therapeutics Reports Landmark Median Overall Survival of 23.8 Months in First-Line Treatment for Unresectable Hepatocellular Carcinoma
May 30, 2024 07:00 ET
|
Elevar Therapeutics
Phase 3 CARES-310 study found combination of camrelizumab and rivoceranib continued to show sustained long-term survival compared with sorafenib as a first-line treatment for uHCCFinal analysis...
- May 30, 2024 07:04 ET Global Polyamide in Electronics Protection Devices Market Projected to Reach $510.9 Million by 2032: Product and Application Advancements Driving Growth, Regional Market Insights and Future Outlook
- May 30, 2024 07:02 ET Incident IQ Partners with Level Access to Enhance Digital Accessibility